“…CEO includes many components such as flavonoids, alkaloids and monoterpenes, and has broad pharmacological efficacy (Osanloo, Sedaghat, Esmaeili, & Amani, 2018; Salim, 2017). Furthermore, the pharmacological effects of mentioned constituents are different, for example, the main site action of flavonoids is acetylcholinesterase (Perumalsamy, Jang, Kim, Kadarkarai, & Ahn, 2015), as well as alkaloids and monoterpenes target Na‐K‐ATPase or Na + and K + channels (Lucia, Zerba, & Masuh, 2013; Rajashekar & Shivanandappa, 2017). The differences between the pharmacological activities of CEO and its isolated compound, E may result from the synergistic or additive effects of the secondary compounds.…”